Study to Assess the Pharmacokinetics, Safety, and Tolerability of Iptacopan in Pediatric PNH Patients
Clinical trial NCT06934967 · RECRUITING
Trial details
- NCT number
- NCT06934967
- Sponsor
- Novartis Pharmaceuticals
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-10-28
- Primary completion
- 2031-10-14
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.